1. As of noon trading, Tenet Healthcare ( THC) is up $2.54 (10.2%) to $27.49 on heavy volume Thus far, 6.6 million shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $25.90-$27.60 after having opened the day at $26.38 as compared to the previous trading day's close of $24.95.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $2.7 billion and is part of the health care sector. The company has a P/E ratio of 45.9, above the S&P 500 P/E ratio of 17.7. Shares are up 17.4% year to date as of the close of trading on Tuesday. Currently there are 3 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity and poor profit margins. Get the full Tenet Healthcare Ratings Report now.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
null

If you liked this article you might like

Centene: Cramer's Top Takeaways

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)

Fidelis Care Buy Could Make Centene Less Likely Takeout Candidate

Tenet Healthcare Is 'Heavily Indebted,' Jim Cramer Warns

Centene Shares Spike on Fidelis Buy